Healthcare - Biotechnology - NASDAQ - US
$ 2.31
-4.55 %
$ 136 M
Market Cap
-1.78
P/E
CASH FLOW STATEMENT
-59.1 M
OPERATING CASH FLOW
37.9 M
INVESTING CASH FLOW
452 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Seer, Inc.
| Net Income | -86.3 M |
| Depreciation & Amortization | 5.58 M |
| Capital Expenditures | -7.31 M |
| Stock-Based Compensation | 34.4 M |
| Change in Working Capital | -2.72 M |
| Others | -10.2 M |
| Free Cash Flow | -66.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (86.3) | (93.0) | (71.2) | (32.8) | (16.0) | (6.3) |
| Depreciation & Amortization | 5.6 | 3.9 | 2.6 | 1.6 | 0.7 | 31 K |
| Deferred Income Tax | 0 | 0 | 1.2 | 0.3 | (0.3) | 0 |
| Stock Based Compensation | 34.4 | 33.7 | 25.9 | 7.3 | 1.6 | 0.7 |
| Other Operating Activities | (10.1) | 2.0 | 1.0 | 10 K | 5 K | 0.5 |
| Change in Working Capital | (2.7) | (7.4) | (5.9) | 2.7 | 1.0 | 1.0 |
| Cash From Operations | (59.1) | (60.8) | (46.3) | (20.8) | (13.1) | (4.7) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (7.3) | (10.3) | (6.9) | (4.5) | (4.1) | (0.2) |
| Other Items | 45.2 | (112.5) | (164.0) | (30.0) | (68.3) | 0 |
| Cash From Investing Activities | 37.9 | (122.7) | (170.9) | (34.6) | (72.4) | (0.2) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 13 K | 20 K | 35 K | 13 K | 6 K | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.5 | 3.9 | 13.7 | 56.2 | 72.3 | 59.8 |
| Cash From Financing Activities | 0.5 | 3.9 | 116.6 | 371.5 | 72.3 | 29.9 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (20.7) | (179.6) | (100.6) | 316.1 | (13.1) | 25.1 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (66.4) | (71.0) | (53.3) | (25.4) | (17.2) | (4.8) |